Ulrike Künzel
AstraZeneca (Australia)(AU)AstraZeneca (Germany)(DE)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Computational Drug Discovery Methods, Cell Adhesion Molecules Research
Most-Cited Works
- → Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling(2017)114 cited
- → Shedding of glycan‐modifying enzymes by signal peptide peptidase‐like 3 ( SPPL 3) regulates cellular N‐glycosylation(2014)109 cited
- → Control of ADAM17 activity by regulation of its cellular localisation(2016)109 cited
- → FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex(2018)77 cited
- → Rhomboid proteases in human disease: Mechanisms and future prospects(2017)69 cited
- → Foamy Virus Envelope Protein Is a Substrate for Signal Peptide Peptidase-like 3 (SPPL3)(2012)44 cited
- → Phytotherapy in adults with recurrent uncomplicated cystitis(2022)8 cited
- → Erratum: Control of ADAM17 activity by regulation of its cellular localisation(2016)8 cited
- → Author response: Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling(2017)3 cited
- → Author response: FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex(2018)2 cited